Altre lingue AstraZeneca Pharma India Limited NSE India S.E.

Azioni

ASTRAZEN

INE203A01020

Tempo differito NSE India S.E. Altri mercati azionari 10:46:09 29/05/2024			Variaz. 5gg	Var. 1 gen.
6.415 ^INR	-0,74%		+11,03%	+15,58%

27/05	AstraZeneca Pharma India Limited riporta i risultati degli utili per il quarto trimestre conclusosi il 31 marzo 2024	CI
27/05	AstraZeneca Pharma India Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	28/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/05
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets	21/05
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	08/04
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	25/03
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11/03
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11/03
Astrazeneca Pharma India Limited Announces Board Changes	20/02
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
AstraZeneca Pharma India Limited Announces Board Changes	08/02
AstraZeneca Pharma India Limited Announces Directorate Appointments	07/02
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	22/01
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	21/12
India's Nifty set for muted open after steep drop	21/12
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	09/11
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
AstraZeneca Gets Indian Drug Regulator's Nod to Import Pharmaceutical Formulations for Palivizumab	02/10/23
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	30/09/23
AstraZeneca Pharma India Limited Announces Management Changes	29/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue AstraZeneca Pharma India Limited NSE India S.E.

Azioni

ASTRAZEN

INE203A01020

Altre lingue

Filtri